Rosuvastatin Tablet, Film Coated
Product Images NDC 50090-7483

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rosuvastatin (NDC 50090-7483). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-01 (Figure 1)

Figure-01 (Figure 1)
A line graph showing cumulative incidence percentage over a 5-year period comparing Rosuvastatin (solid line) and Placebo (dashed line). The graph indicates a lower cumulative incidence with Rosuvastatin. Included is a hazard ratio (HR) of 0.56 with a 95% confidence interval (0.46-0.69) and a p-value less than 0.001. Below the graph, numbers at risk for RSV and Placebo groups are listed at various time points.*
FDA Label Image

Figure-02 (Figure 2)

Figure-02 (Figure 2)
A data table presenting clinical event rates comparing Rosuvastatin 20 mg versus placebo 20 mg. It lists primary and secondary endpoints such as primary end point (MCE), cardiovascular death, nonfatal stroke, nonfatal myocardial infarction, hospitalized unstable angina, and arterial revascularization. Columns show number of events, event rates per 1000 patient-years, hazard ratios (HR with 95% CI), and P values. The table includes a hazard ratio plot illustrating risk differences between treatment groups.*
FDA Label Image

Figure-02 (Figure 3)

Figure-02 (Figure 3)
Box plot chart depicting the percent change from baseline in LDL-C levels for four statins: Rosuvastatin, Atorvastatin, Simvastatin, and Pravastatin. The x-axis shows doses in mg, and the y-axis shows percent change from baseline with a scale from 0 to -75. The chart compares LDL-C reduction across different dosages for each drug.*
FDA Label Image

Label Image (Lbl500907483)

Label Image (Lbl500907483)
Rosuvastatin 40 mg film-coated tablets label from A-S Medication Solutions. The label includes storage instructions to keep the tablets at 68 to 77 degrees Fahrenheit, protecting them from moisture. The package contains 90 tablets. Dosage and package insert information is indicated to be included separately.*
FDA Label Image

Structural Formula (Rosuvastatin Str)

Structural Formula (Rosuvastatin Str)
Chemical structure diagram of Rosuvastatin calcium, showing the molecular arrangement including a fluorophenyl group, a pyrimidine ring, and functional groups like hydroxyls and a sulfate methyl group, with calcium ions indicated.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.